See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Carmat raises $66M to boost clinical, commercial development of its TAH

Oct. 9, 2019
By Bernard Banga
PARIS – Carmat SA, from Vélizy Villacoublay, France, has just raised $66 million from European specialist investors in the life sciences and medical technologies sector.
BioWorld MedTech Financings Cardiovascular Artificial organ Europe